139 related articles for article (PubMed ID: 20190819)
21. PI3K/Akt-dependent Epo-induced signalling and target genes in human early erythroid progenitor cells.
Sivertsen EA; Hystad ME; Gutzkow KB; Døsen G; Smeland EB; Blomhoff HK; Myklebust JH
Br J Haematol; 2006 Oct; 135(1):117-28. PubMed ID: 16965383
[TBL] [Abstract][Full Text] [Related]
22. Oncogene cooperativity in Friend erythroleukemia: erythropoietin receptor activation by the env gene of SFFV leads to transcriptional upregulation of PU.1, independent of SFFV proviral insertion.
Afrikanova I; Yeh E; Bartos D; Watowich SS; Longmore GD
Oncogene; 2002 Feb; 21(8):1272-84. PubMed ID: 11850847
[TBL] [Abstract][Full Text] [Related]
23. PU.1 silencing leads to terminal differentiation of erythroleukemia cells.
Atar O; Levi BZ
Biochem Biophys Res Commun; 2005 Apr; 329(4):1288-92. PubMed ID: 15766566
[TBL] [Abstract][Full Text] [Related]
24. PU.1 positively regulates GATA-1 expression in mast cells.
Takemoto CM; Brandal S; Jegga AG; Lee YN; Shahlaee A; Ying Y; Dekoter R; McDevitt MA
J Immunol; 2010 Apr; 184(8):4349-61. PubMed ID: 20304827
[TBL] [Abstract][Full Text] [Related]
25. Spi-1/PU.1 is a positive regulator of the Fli-1 gene involved in inhibition of erythroid differentiation in friend erythroleukemic cell lines.
Starck J; Doubeikovski A; Sarrazin S; Gonnet C; Rao G; Skoultchi A; Godet J; Dusanter-Fourt I; Morle F
Mol Cell Biol; 1999 Jan; 19(1):121-35. PubMed ID: 9858537
[TBL] [Abstract][Full Text] [Related]
26. Spi-1/PU.1 participates in erythroleukemogenesis by inhibiting apoptosis in cooperation with Epo signaling and by blocking erythroid differentiation.
Rimmelé P; Kosmider O; Mayeux P; Moreau-Gachelin F; Guillouf C
Blood; 2007 Apr; 109(7):3007-14. PubMed ID: 17132716
[TBL] [Abstract][Full Text] [Related]
27. PU.1 is dispensable to block erythroid differentiation in Friend erythroleukemia cells.
Fernández-Nestosa MJ; Hernández P; Schvartzman JB; Krimer DB
Leuk Res; 2008 Jan; 32(1):121-30. PubMed ID: 17586044
[TBL] [Abstract][Full Text] [Related]
28. Alterations of the phosphoinositide 3-kinase and mitogen-activated protein kinase signaling pathways in the erythropoietin-independent Spi-1/PU.1 transgenic proerythroblasts.
Barnache S; Mayeux P; Payrastre B; Moreau-Gachelin F
Blood; 2001 Oct; 98(8):2372-81. PubMed ID: 11588033
[TBL] [Abstract][Full Text] [Related]
29. PU.1 can regulate the ZNF300 promoter in APL-derived promyelocytes HL-60.
Xu JH; Wang T; Wang XG; Wu XP; Zhao ZZ; Zhu CG; Qiu HL; Xue L; Shao HJ; Guo MX; Li WX
Leuk Res; 2010 Dec; 34(12):1636-46. PubMed ID: 20471086
[TBL] [Abstract][Full Text] [Related]
30. Spi-1/PU.1 oncogene accelerates DNA replication fork elongation and promotes genetic instability in the absence of DNA breakage.
Rimmelé P; Komatsu J; Hupé P; Roulin C; Barillot E; Dutreix M; Conseiller E; Bensimon A; Moreau-Gachelin F; Guillouf C
Cancer Res; 2010 Sep; 70(17):6757-66. PubMed ID: 20660370
[TBL] [Abstract][Full Text] [Related]
31. Induction of apoptosis by overexpression of the PU. 1/Spi-1 gene in murine erythroleukemia cells.
Yamada T; Oikawa T
Leukemia; 1997 Apr; 11 Suppl 3():480-1. PubMed ID: 9209431
[No Abstract] [Full Text] [Related]
32. Correlation of PU.1 and signal regulatory protein α1 expression in PU.1 transgenic K562 cells.
Iseki Y; Nakahara M; Kubo M; Obata F; Harigae H; Takahashi S
Int J Mol Med; 2012 Feb; 29(2):319-23. PubMed ID: 22075620
[TBL] [Abstract][Full Text] [Related]
33. Genome-wide comparison of PU.1 and Spi-B binding sites in a mouse B lymphoma cell line.
Solomon LA; Li SK; Piskorz J; Xu LS; DeKoter RP
BMC Genomics; 2015 Feb; 16(1):76. PubMed ID: 25765478
[TBL] [Abstract][Full Text] [Related]
34. Potential autoregulation of transcription factor PU.1 by an upstream regulatory element.
Okuno Y; Huang G; Rosenbauer F; Evans EK; Radomska HS; Iwasaki H; Akashi K; Moreau-Gachelin F; Li Y; Zhang P; Göttgens B; Tenen DG
Mol Cell Biol; 2005 Apr; 25(7):2832-45. PubMed ID: 15767686
[TBL] [Abstract][Full Text] [Related]
35. Germ-line deletion of p53 reveals a multistage tumor progression in spi-1/PU.1 transgenic proerythroblasts.
Scolan EL; Wendling F; Barnache S; Denis N; Tulliez M; Vainchenker W; Moreau-Gachelin F
Oncogene; 2001 Sep; 20(39):5484-92. PubMed ID: 11571646
[TBL] [Abstract][Full Text] [Related]
36. Functional regulation of pre-B-cell leukemia homeobox interacting protein 1 (PBXIP1/HPIP) in erythroid differentiation.
Manavathi B; Lo D; Bugide S; Dey O; Imren S; Weiss MJ; Humphries RK
J Biol Chem; 2012 Feb; 287(8):5600-14. PubMed ID: 22187427
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of PU.1 induces growth and differentiation inhibition and apoptotic cell death in murine erythroleukemia cells.
Yamada T; Kondoh N; Matsumoto M; Yoshida M; Maekawa A; Oikawa T
Blood; 1997 Feb; 89(4):1383-93. PubMed ID: 9028962
[TBL] [Abstract][Full Text] [Related]
38. PU.1 directly regulates cdk6 gene expression, linking the cell proliferation and differentiation programs in erythroid cells.
Choe KS; Ujhelly O; Wontakal SN; Skoultchi AI
J Biol Chem; 2010 Jan; 285(5):3044-52. PubMed ID: 19955566
[TBL] [Abstract][Full Text] [Related]
39. Proteasome-mediated proteolysis of SRSF5 splicing factor intriguingly co-occurs with SRSF5 mRNA upregulation during late erythroid differentiation.
Breig O; Baklouti F
PLoS One; 2013; 8(3):e59137. PubMed ID: 23536862
[TBL] [Abstract][Full Text] [Related]
40. 5-azacitidine in aggressive myelodysplastic syndromes regulates chromatin structure at PU.1 gene and cell differentiation capacity.
Curik N; Burda P; Vargova K; Pospisil V; Belickova M; Vlckova P; Savvulidi F; Necas E; Hajkova H; Haskovec C; Cermak J; Krivjanska M; Trneny M; Laslo P; Jonasova A; Stopka T
Leukemia; 2012 Aug; 26(8):1804-11. PubMed ID: 22343522
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
